Search | DIAL.pr - BOREAL

Accès à distance ? S'identifier sur le proxy UCLouvain

Displaying 2 results.

- Journal article
Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis: the ACCESS randomized trial.
Opal, Steven M Laterre, Pierre-François[UCL] Francois, Bruno LaRosa, Steven P Angus, Derek C Mira, Jean-Paul Wittebole, Xavier[UCL] Dugernier, Thierry Perrotin, Dominique Tidswell, Mark Jauregui, Luis Krell, Kenneth Pachl, Jan Takahashi, Takeshi Peckelsen, Claus Cordasco, Edward Chang, Chia-Sheng Oeyen, Sandra Aikawa, Naoki Maruyama, Tatsuya Schein, Roland Kalil, Andre C Van Nuffelen, Marc Lynn, Melvyn Rossignol, Daniel P Gogate, Jogadish Roberts, Mary B Wheeler, Janice L Vincent, Jean-Louis ACCESS Study Group. (2013) JAMA : the journal of the American Medical Association — Vol. 309, no.11, p. 1154 [1-9] (2013)
- Journal article
Recombinant human platelet-activating factor acetylhydrolase for treatment of severe sepsis: Results of a phase III, multicenter, randomized, double-blind, placebo-controlled, clinical trial
Opal, Steven Laterre, Pierre-François[UCL] Abraham, Edward Francois, Bruno Wittebole, Xavier[UCL] Lowry, Stephen Dhainaut, Jean-François Warren, Brian Dugernier, Thierry Lopez, Angel Sanchez, Miguel Demeyer, Ignace Jauregui, Luis Lorente, Jose Angel McGee, William Reinhart, Konrad Kljucar, Sascha Souza, Sonia Pribble, John (2004) Critical Care Medicine — Vol. 32, no. 2, p. 332-341 (2004)